Millennium Management’s Biohaven BHVN Stock Holding History

Millennium Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-400,000	Closed	-$6M	–	6018
2025 Q3	$6M	Sell	400,000 -380,000	-49%	-$5.53M	﹤0.01%	2947
2025 Q2	$11M	Buy	+780,000	New	+$13.9M	0.01%	2166
2025 Q1	–	Sell	-65,000	Closed	-$2.43M	–	5870
2024 Q4	$2.43M	Buy	65,000 +10,000	+18%	+$467K	﹤0.01%	3473
2024 Q3	$2.75M	Buy	+55,000	New	+$2.14M	﹤0.01%	3401
2024 Q2	–	Sell	-25,000	Closed	-$1.37M	–	5896
2024 Q1	$1.37M	Buy	25,000 +3,300	+15%	+$163K	﹤0.01%	4043
2023 Q4	$929K	Buy	+21,700	New	+$675K	﹤0.01%	4219
2023 Q3	–	Sell	-89,100	Closed	-$2.13M	–	6128
2023 Q2	$2.13M	Buy	89,100 +9,100	+11%	+$157K	﹤0.01%	3431
2023 Q1	$1.09M	Buy	+80,000	New	+$1.27M	﹤0.01%	4007
2022 Q4	–	Sell	-139,844	Closed	-$20.7M	–	6574
2022 Q3	$20.7M	Buy	+139,844	New	+$1.01M	0.01%	1317

Other funds holding BHVN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $173M AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management's BHVN Position: Q1 2026 in Review

Millennium Management increased its Biohaven (BHVN) stake by 9.3% in Q1 2026, buying an estimated $1.35M and bringing the position to 1,447,886 shares worth $12.2M. The position accounts for 0.01% of the portfolio, ranked #1973.

Millennium Management first reported a position in BHVN in Q3 2022 and has held it in 11 quarters since. The position peaked at $153M in Q3 2022. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

Millennium Management held 1,447,886 shares of Biohaven worth $12.2M as of Q1 2026.
Millennium Management bought 123,639 Biohaven shares in Q1 2026, an estimated $1.35M.
Biohaven made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1973 holding.
Millennium Management first reported a position in Biohaven in Q3 2022 and has held it in 11 quarters since.
Millennium Management's Biohaven position peaked at $153M in Q3 2022.
275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.